SCHEMBL20127627

SCHEMBL20127627

c1ccc(-n2c3ccccc3c3cc(-c4ccc(-c5c6ccccc6c(-c6ccc7oc8c(ccc9c%10ccccc%10oc98)c7c6)c6ccccc56)cc4)ccc32)cc1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 4/20 0.42
ATM Q13315 1/20 0.42
L3MBTL1 Q9Y468 1/20 0.42
PLA2G2A P14555 3/20 0.36
PLA2G4A P47712 3/20 0.36
KMT2A Q03164 4/20 0.34
ALDH1A1 P00352 4/20 0.34
PPARG P37231 1/20 0.34
RXFP1 Q9HBX9 1/20 0.34
NR2E3 Q9Y5X4 1/20 0.34
NCOR2 Q9Y618 1/20 0.34
ALOX5 P09917 1/20 0.34
MEN1 O00255 3/20 0.33
TSHR P16473 2/20 0.33
HSD17B10 Q99714 2/20 0.33
POLB P06746 2/20 0.33
BRCA1 P38398 1/20 0.33
PLA2G10 O15496 1/20 0.33
TSPO P30536 1/20 0.32
HDAC4 P56524 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20127612 0.96 KDM4E (0.45) KDM4EATML3MBTL1PLA2G2APLA2G4A
SCHEMBL20127626 0.94 KDM4E (0.41) KDM4EATML3MBTL1PLA2G2APLA2G4A
SCHEMBL1636966 0.93 KDM4E (0.46) KDM4EATML3MBTL1PLA2G2APLA2G4A
SCHEMBL20127622 0.93 KDM4E (0.39) KDM4EATML3MBTL1PLA2G2APLA2G4A
SCHEMBL1635816 0.92 L3MBTL1 (0.47) KDM4EATML3MBTL1PLA2G2APLA2G4A
SCHEMBL1635554 0.92 KDM4E (0.50) KDM4EATML3MBTL1PLA2G2APLA2G4A
SCHEMBL1635568 0.92 KDM4E (0.42) KDM4EATML3MBTL1PLA2G2APLA2G4A
SCHEMBL20321542 0.91 KDM4E (0.44) KDM4EATML3MBTL1PLA2G2APLA2G4A
SCHEMBL16067697 0.90 KDM4E (0.39) KDM4EATML3MBTL1KMT2AALDH1A1
SCHEMBL5946848 0.89 PLA2G2A (0.40) KDM4EATML3MBTL1PLA2G2APLA2G4A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20180208836-A1 ORGANIC ELECTROLUMINESCENCE ELEMENT AND ELECTRONIC DEVICE IDEMITSU KOSAN CO., LTD. (JP) 2018-07-26 US disclosed
US-20180208836-A1 ORGANIC ELECTROLUMINESCENCE ELEMENT AND ELECTRONIC DEVICE IDEMITSU KOSAN CO., LTD. (JP) 2018-07-26 US disclosed
US-20180130968-A1 ORGANIC ELECTROLUMINESCENCE ELEMENT AND ELECTRONIC DEVICE IDEMITSU KOSAN CO., LTD. (JP) 2018-05-10 US disclosed
US-20180130968-A1 ORGANIC ELECTROLUMINESCENCE ELEMENT AND ELECTRONIC DEVICE IDEMITSU KOSAN CO., LTD. (JP) 2018-05-10 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180130968-A1 ORGANIC ELECTROLUMINESCENCE ELEMENT AND ELECTRONIC DEVICE RER1, NR0B1, NR2E1 KDM4E 4144/4885ATM 3954/4885L3MBTL1 1670/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.